<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Start-up Exclusive License: Scopolamine for the Treatment of Depression and Anxiety</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Start-up Exclusive License: Scopolamine for the Treatment of Depression and Anxiety</h1>
    <p class="timestamp">Published: 2015-01-21 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Patent License to Biohaven Pharmaceuticals Holding Company having its principal place of business in New Haven, Connecticut. The contemplated license would be for the inventions claimed in U.S. Utility Patent Number 8,859,585, issued October 14, 2014 (filed May 25, 2005), PCT Patent Applicat...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2015-00811</p>
    <p><strong>Publication Date:</strong> 2015-01-21</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/01/21/2015-00811/prospective-grant-of-start-up-exclusive-license-scopolamine-for-the-treatment-of-depression-and">https://www.federalregister.gov/documents/2015/01/21/2015-00811/prospective-grant-of-start-up-exclusive-license-scopolamine-for-the-treatment-of-depression-and</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2015-00811</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
